Advanced Accelerator Applications

The sponsor demonstrates a focused commitment to advancing therapeutic options for patients with neuroendocrine tumors, a complex group of malignancies arising from hormone-producing cells. Research efforts concentrate on developing innovative treatment approaches that target the unique biological characteristics of these tumors, particularly their expression of specific cellular receptors that enable targeted therapeutic interventions.

• Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
• Somatostatin receptor-expressing neoplasms
• Advanced neuroendocrine malignancies

The therapeutic programs emphasize precision medicine strategies that leverage molecular targeting mechanisms to improve outcomes for patients with these relatively rare but challenging malignancies.